{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:14:15Z","timestamp":1783779255965,"version":"3.55.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,5]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      The Food Inflammation Index (FII) is a novel indicator for assessing the impact of diet on systemic inflammation. Unlike the Dietary Inflammation Index, which focuses on nutrients, the FII quantifies specific foods, providing greater applicability to real-world dietary assessments. To date, no study has examined the association between FII and the prevalence of Metabolic dysfunction-associated fatty liver disease (MAFLD). This study aimed to investigate the relationship between FII and MAFLD. This cross-sectional study included 25,067 individuals aged\u2005\u2265\u200520 years from the 1999 to 2020 National Health and Nutrition Examination Survey (NHANES). Univariate and multivariate logistic regression analyses were performed to explore the relationship between FII and MAFLD. Nonlinear associations between FII and MAFLD were examined using restricted cubic spline (RCS) analysis. Subgroup analyses, interaction tests, and threshold effect analyses were conducted to assess differences across groups. The prevalence of MAFLD was 44.45%. FII was positively associated with MAFLD in all models (Models 1, 2, and 3,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05). In model 3, individuals in the highest tertile of FII had an odds ratio (OR) of 1.21 [95% confidence interval (CI): 1.11\u20131.32] for MAFLD, compared to those in the lowest tertile. Subgroup analyses and interaction tests revealed sex- and race-specific associations between FII and MAFLD. Among non-Hispanic whites, the optimal FII threshold for preventing MAFLD was found to be -11.56. A lower FII was associated with a lower prevalence of MAFLD. The impact of FII on MAFLD prevalence was more pronounced among non-Hispanic whites compared to other racial groups. An FII score of\u2005&lt;\u2005-11.56 for daily food intake was associated with a reduced risk of MAFLD in non-Hispanic whites.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049152","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:00:22Z","timestamp":1780718422000},"page":"e49152","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Exploring racial-specific associations between the food inflammation index(FII) and metabolic dysfunction-associated fatty liver disease (MAFLD) Prevalence: Data from the National Health and Nutrition Examination Survey 1999\u20132020"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6673-0020","authenticated-orcid":false,"given":"Shiyan","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8523-1689","authenticated-orcid":false,"given":"Enqiang","family":"Chen","sequence":"additional","affiliation":[{"name":"Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"Suppl","key":"R1-20260711","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.3350\/cmh.2022.0367","article-title":"MAFLD: How is it different from NAFLD?","volume":"29","author":"Gofton","year":"2023","journal-title":"Clin Mol Hepatol"},{"issue":"Suppl 2","key":"R2-20260711","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s12072-024-10660-y","article-title":"MAFLD as part of systemic metabolic dysregulation.","volume":"18","author":"Zhao","year":"2024","journal-title":"Hepatol Int"},{"key":"R3-20260711","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement.","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"R4-20260711","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jhep.2020.12.016","article-title":"Clinical utility of the MAFLD definition.","volume":"74","author":"Zheng","year":"2021","journal-title":"J Hepatol"},{"key":"R5-20260711","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1210\/clinem\/dgac321","article-title":"Global prevalence and clinical characteristics of metabolic-associated fatty liver disease: a meta-analysis and systematic review of 10 739 607 individuals.","volume":"107","author":"Chan","year":"2022","journal-title":"J Clin Endocrinol Metabol"},{"key":"R6-20260711","first-page":"972","article-title":"Epidemiology and clinical outcomes of metabolic (dysfunction)-associated fatty liver disease.","volume":"9","author":"Lin","year":"2021","journal-title":"J Clin Transl Hepatol"},{"key":"R7-20260711","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis.","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"R8-20260711","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature21363","article-title":"Inflammation, metaflammation and immunometabolic disorders.","volume":"542","author":"Hotamisligil","year":"2017","journal-title":"Nature"},{"key":"R9-20260711","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI29069","article-title":"Inflammation and insulin resistance.","volume":"116","author":"Shoelson","year":"2006","journal-title":"J Clin Invest"},{"key":"R10-20260711","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.metabol.2014.10.012","article-title":"Leptin in nonalcoholic fatty liver disease: a narrative review.","volume":"64","author":"Polyzos","year":"2015","journal-title":"Metabolism"},{"key":"R11-20260711","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.27332","article-title":"Hepatic inflammation and fibrosis: functional links and key pathways.","volume":"61","author":"Seki","year":"2015","journal-title":"Hepatology"},{"key":"R12-20260711","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.3390\/nu14214505","article-title":"Dietary quality and relationships with metabolic dysfunction-associated fatty liver disease (MAFLD) among United States adults, results from NHANES 2017\u20132018.","volume":"14","author":"Tian","year":"2022","journal-title":"Nutrients"},{"key":"R13-20260711","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies.","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"R14-20260711","doi-asserted-by":"crossref","first-page":"e13349","DOI":"10.1111\/obr.13349","article-title":"The dietary inflammatory index, obesity, type 2 diabetes, and cardiovascular risk factors and diseases.","volume":"23","author":"Hariharan","year":"2022","journal-title":"Obes Rev"},{"key":"R15-20260711","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1017\/S1368980013002115","article-title":"Designing and developing a literature-derived, population-based dietary inflammatory index.","volume":"17","author":"Shivappa","year":"2014","journal-title":"Public Health Nutr"},{"key":"R16-20260711","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/nu10081033","article-title":"Dietary inflammatory index and biomarkers of lipoprotein metabolism, inflammation and glucose homeostasis in adults.","volume":"10","author":"Phillips","year":"2018","journal-title":"Nutrients"},{"key":"R17-20260711","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12916-023-02793-y","article-title":"Associations between an inflammatory diet index and severe non-alcoholic fatty liver disease: a prospective study of 171,544 UK Biobank participants.","volume":"21","author":"Petermann-Rocha","year":"2023","journal-title":"BMC Med"},{"key":"R18-20260711","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s40795-023-00738-5","article-title":"Dietary inflammatory index (DII) is correlated with the incidence of non-alcoholic fatty liver disease (NAFLD): Fasa PERSIAN cohort study.","volume":"9","author":"Valibeygi","year":"2023","journal-title":"BMC Nutr"},{"key":"R19-20260711","doi-asserted-by":"crossref","first-page":"1340453","DOI":"10.3389\/fnut.2024.1340453","article-title":"Dietary inflammatory index is associated with metabolic dysfunction-associated fatty liver disease among United States adults.","volume":"11","author":"Yan","year":"2024","journal-title":"Front Nutr"},{"key":"R20-20260711","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41575-024-00893-5","article-title":"Ultra-processed foods and food additives in gut health and disease.","volume":"21","author":"Whelan","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R21-20260711","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jare.2024.10.010","article-title":"Food inflammation index reveals the key inflammatory components in foods and heterogeneity within food groups: How do we choose food?","volume":"74","author":"Wang","year":"2024","journal-title":"J Adv Res"},{"key":"R22-20260711","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ajg.2024.02.003","article-title":"Dietary composition and its association with metabolic dysfunction-associated fatty liver disease among Chinese adults: a cross-sectional study.","volume":"25","author":"Niu","year":"2024","journal-title":"Arab J Gastroenterol"},{"key":"R23-20260711","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41387-024-00261-x","article-title":"The prognostic role of diet quality in patients with MAFLD and physical activity: data from NHANES.","volume":"14","author":"Huang","year":"2024","journal-title":"Nutr Diabetes"},{"key":"R24-20260711","doi-asserted-by":"crossref","first-page":"1081706","DOI":"10.3389\/fpubh.2023.1081706","article-title":"A cross-sectional study of smoking and depression among US adults: NHANES (2005-2018).","volume":"11","author":"Wu","year":"2023","journal-title":"Front Public Health"},{"key":"R25-20260711","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/hep.32642","article-title":"Metabolic dysfunction-associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality.","volume":"77","author":"van Kleef","year":"2023","journal-title":"Hepatology"},{"key":"R26-20260711","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/CM9.0000000000002753","article-title":"Hypertension and NAFLD risk: Insights from the NHANES 2017-2018 and Mendelian randomization analyses.","volume":"137","author":"Yuan","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"R27-20260711","doi-asserted-by":"crossref","first-page":"1331159","DOI":"10.3389\/fpubh.2023.1331159","article-title":"Association between systemic immune-inflammatory index and diabetes mellitus: mediation analysis involving obesity indicators in the NHANES.","volume":"11","author":"Chen","year":"2023","journal-title":"Front Public Health"},{"key":"R28-20260711","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12933-023-02115-9","article-title":"The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003-2018.","volume":"23","author":"Dang","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"R29-20260711","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s42255-021-00501-9","article-title":"Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity.","volume":"3","author":"Tilg","year":"2021","journal-title":"Nat Metab"},{"key":"R30-20260711","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1194\/jlr.R067595","article-title":"The role of ER stress in lipid metabolism and lipotoxicity.","volume":"57","author":"Han","year":"2016","journal-title":"J Lipid Res"},{"key":"R31-20260711","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.peptides.2018.07.008","article-title":"Sex differences in body fat distribution are related to sex differences in serum leptin and adiponectin.","volume":"107","author":"Christen","year":"2018","journal-title":"Peptides"},{"key":"R32-20260711","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps.","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"key":"R33-20260711","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1194\/jlr.P067454","article-title":"Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study.","volume":"58","author":"Krawczyk","year":"2017","journal-title":"J Lipid Res"},{"key":"R34-20260711","doi-asserted-by":"crossref","first-page":"795421","DOI":"10.3389\/fmed.2021.795421","article-title":"Sex-specific differences in the association between race\/ethnicity and NAFLD among US population.","volume":"8","author":"Shaheen","year":"2021","journal-title":"Front Med (Lausanne)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000049152","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:00:33Z","timestamp":1783778433000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000049152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":34,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049152","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"2026-01-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}